ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference
LOS ANGELES, January 26, 2024--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, today announced that its Chi...